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Available online xxxxBackground: Following the development of breakthrough techniques for percutaneous coronary intervention
(PCI) in the treatment of chronic total occlusions (CTO), the initial success rate of PCI in CTO lesions (CTO-PCI)
has improved; however, there are few reports regarding the effects of successful CTO revascularization on
long-term mortality in Japan. The aim of this study was to compare the long-term clinical outcomes of patients
with successful versus failed CTO recanalization and to identify related factors.
Methods and results: From all PCI procedures performed in our hospital between 2006 and 2013, CTO-PCIs were
extracted and classiﬁed into two groups: PCI success (n = 656 patients) and PCI failure (n = 82 patients). Pa-
tients with successful procedures only on a second attempt, CTO-PCI in small branches, or CTOs in more than
one vessel were excluded. Survival was determined from a telephone interview or the consultation history in
the outpatient clinic. Initial angiographic success was achieved in 88.9% of the patients. A Kaplan–Meier plot
with log-rank analysis showed that cumulative all-cause death was signiﬁcantly lower in the success group
than in the failure group (p = 0.0003; average follow-up duration in success group vs. failure group was
1531.3 ± 33.5 vs. 1565.3 ± 97.5 days, p = 0.7). Moreover, the rate of evident cardiac death was signiﬁcantly
lower in the success group than in the failure group (3.5% [23/656] vs. 15.9% [13/82], p b 0.0001).
Conclusions: This study suggests that successful revascularization in patients with CTO improves their long-term
clinical outcomes.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND li-
cense (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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The technology and techniques for the interventional treatment of
chronic total occlusion (CTO) in patients with coronary artery disease
have advanced signiﬁcantly over recent years, and have contributed to
the higher initial success rate of percutaneous coronary intervention
(PCI) for treating CTO (CTO-PCI) [1,2]. However, the effect of this im-
provement on the chronic outcomes of patients who undergo CTO-PCI
is still unclear. It has been reported that successful CTO-PCI might be as-
sociatedwith symptom relief, a lower rate of subsequentmyocardial in-
farction (MI) and coronary artery bypass graft (CABG) surgery, and
improved long-term survival, compared with unsuccessful PCI [3–7].
While the initial success rate of CTO-PCI has also reached an acceptable
level in Japan, with an acute result that is widely recognized to be betterular Medicine, Toyohashi Heart
1-8530, Japan.
land Ltd. This is an open access articlthan in other countries, its long-term outcome has not been fully inves-
tigated. Therefore, the aim of this study was to compare the long-term
clinical outcomes of patients with successful versus failed CTO recanali-
zation and to identify related factors.
2. Methods
2.1. Study design
Consecutive patients who underwent CTO-PCI were extracted from
the database at Toyohashi Heart Center, Toyohashi, Japan, in which
datawere enteredprospectively. The database included relevant patient
information as well as angiographic and procedural characteristics. A
total of 7353 PCI procedures performed between 2006 and 2013 were
screened for this study, of which 848 involved revascularization of a
CTO. Any patients with CTOs in more than one vessel or lesions in a
small coronary branch vessel, as well as those in whom a repeat proce-
dure succeeded after an initial failure, were excluded from the study, as
were 17 patients who were untraceable (Fig. 1). We excluded patientse under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
29T. Teramoto et al. / IJC Heart & Vasculature 14 (2017) 28–32with CTO lesions in more than one vessel in order to evaluate the effect
of a single CTO-PCI recanalization, while small-branch lesions were ex-
cluded because of the known lesser clinical advantage in such cases. The
remaining 738 patients represented the total population of this study.
These patients were then classiﬁed into 2 study groups: those with suc-
cessful CTO-PCI (success group; 656 patients) and those with failed
CTO-PCI (failed group; 82 patients) (Fig. 1). The protocol was approved
by the ethics committees in each participating center and all partici-
pants gave written informed consent. The PCI and stent implantation
were performed in a standard manner. Heparin was administered to
maintain an activated clotting time N 250 s. The PCI strategy was left
to the discretion of the treating physician. The PCI of the CTO was per-
formed using contemporary techniques as they became available: bilat-
eral injection; specialized hydrophilic, tapered-tip, and stiff wires;
parallel wires; micro-catheters; and a retrograde approach. In this
study, all the stents deployed were drug-eluting stents (DES). After
PCI, all patients were prescribed lifelong aspirin; in addition, clopidogrel
was prescribed for at least 6 months after implantation of DES. Demo-
graphic and procedural data for all patients undergoing PCI were pro-
spectively entered into a dedicated database. Patients were followed
prospectively by telephone interview or on regular outpatient visits.
2.2. Deﬁnitions
Coronary CTO is deﬁned as a true total occlusion with complete in-
terruption of antegrade blood ﬂow as assessed by coronary arteriogra-
phy (Thrombolysis In Myocardial Infarction [TIMI] ﬂow grade 0) and
with an estimated occlusion duration of 3 months or more. For the pro-
cedural background inherent in this study, we examined the total
amount of contrast medium, procedure time, and radiation dose. Proce-
dure timewas deﬁned as the total duration for which the patient was in
the catheterization room (from entry until exit). Fluoroscopy time and
radiation dose were recorded automatically by the cine device. Coro-
nary perforation was examined as a complication during the procedure.
The following endpoints were evaluated to compare patients with a
failed versus a successful procedure: all-cause death, evident cardiac
death, MI, and subsequent coronary artery bypass grafting (CABG).
The following deﬁnitions were used:Fig. 1. Flow diagram of the study population. PCI procedures performed between 2006 and 201
CTO = chronic total occlusion; PCI = percutaneous coronary intervention.• Evident cardiac death was deﬁned as death within 7 days after MI,
death associated with cardiovascular interventions within 30 days
after CABG or within 7 days after PCI, or unexpected death presumed
to bedue to ischemic cardiovascular disease and arrhythmia occurring
within 24 h after the onset of symptoms, without clinical or postmor-
temevidence of another cause, as judged according to the information
from the telephone interview. Death from uncertain causes was also
classiﬁed as cardiac death.
• Double CTO was deﬁned as the presence of a CTO lesion in more than
one vessel at the same time.
• Procedural successwas deﬁned as residual stenosis less than 50%with
TIMI ﬂow grade 3 and without major adverse cardiovascular events.
• MI was diagnosed by an increase in creatine kinase level to twice the
upper limit of normal.
2.3. Guidewire crossing strategies
Guidewire crossing strategies were followed in a stepwise manner,
as described in our previous report [8]. Brieﬂy, as for antegrade
approaches, singlewiring, parallelwiring, andwiring techniques guided
by intravascular ultrasound (IVUS) were included. For retrograde
attempts, retrogradewire cross, kissingwire cross, controlled antegrade
and retrograde subintimal tracking (CART), and reverse CART (r-CART)
techniques were performed.
2.4. Statistical analysis
Data distribution was assessed by the F-test. Variables that did not
follow a normal distribution were expressed as medians and interquar-
tile ranges, whereas other continuous variables were expressed as
mean ± standard error. Student's t-test or the Mann–Whitney U test
was used for the comparison of continuous variables, as appropriate.
Event rates were estimated using the Kaplan–Meier method. Follow-
up was censored at date of last follow-up or at 7 years, whichever
came ﬁrst. Survival curves with all available follow-up data were con-
structed for time-to-event variables using Kaplan–Meier methodology3. The ﬂowchart indicates lesions, exclusions, and the composition of the study population.
Table 2
Lesion and procedural characteristics in the success and failure groups.
Variables Success (656 pts) Failure (82 pts) p-Value
Target vessel
LAD 201 (30.6) 16 (19.5)
9>=
>;
0.01
RCA 323 (49.1) 37 (45.1)
LCX 129 (19.7) 28 (34.2)
LMT 3 (0.6) 1 (1.2)
Calciﬁcation
None 194 (29.5) 27 (32.8)
9>=
>;
b0.0001
Mild 228 (34.7) 16 (19.5)
Moderate 175 (26.6) 17 (20.7)
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follow-up were censored at the time of the last contact. Logistic regres-
sion analysis was used to identify the independent predictors for the
procedural success of CTO-PCI. The predictors of the multivariate
model were entered if their univariate p-value was at the p = 0.1
level. The results are reported as odds ratios (OR) with associated con-
ﬁdence intervals (CI). An OR of b1 indicated better mortality, while
that of N1 indicated worse. A value of p b 0.05 was considered statisti-
cally signiﬁcant, and all reported p-values were two-sided. Statistical
analysis was performed using SAS software (SAS Institute, Cary, North
Carolina).Severe 59 (9.0) 22 (27.0)
Tortuosity
None 511 (77.9) 54 (65.9)
9=
;
0.001
Moderate 111 (16.9) 18 (21.9)
Severe 34 (5.2) 10 (12.2)
Amount of contrast (mL) 285.3 ± 5.9 307.5 ± 18.5 0.37
Procedure time (min) 184.4 ± 3.4 236.0 ± 10.7 b0.0001
Radiation dose (frontal) (Gy) 4.7 ± 0.2 6.4 ± 0.6 0.002
Radiation dose (lateral) (Gy) 4.3 ± 0.2 4.5 ± 0.4 0.80
Coronary perforation 59 (9.0) 26 (31.7) b0.0001
CK at 24 h 204.2 ± 19.0 221.9 ± 36.9 0.74
Initial success rate 88.1%
Values are number, (%); LAD = left anterior descending artery; RCA = right coronary
artery; LCX= left circumﬂex; LMT= leftmain trunk artery; PCI=percutaneous coronary
intervention; CK = creatine kinase.3. Results
3.1. Patient, lesion and procedural characteristics
Baseline patient characteristics are shown in Table 1. Renal insufﬁ-
ciency requiring hemodialysis after the procedure (serum creatinine
level N 2 mg/dL) was observed more often in the failed group than in
the success group (12.4% [11/89] vs. 5.8% [38/656]; p=0.007). Notably,
the mean preprocedural creatinine level was signiﬁcantly higher in the
failed group than in the success group (1.4 ± 0.1 vs. 2.0 ± 0.3 mg/dL;
p = 0.03). Preprocedural LVEF obtained by echocardiography was
lower in the failed patients (50.4 ± 12.5 vs. 45.8 ± 12.8; p = 0.04). Le-
sion and procedural characteristics in both groups are shown in Table 2.
CTO lesionswere located predominantly in the right coronary artery. Al-
though this tendencywas similar in both groups, CTO in the left circum-
ﬂex artery was observed more frequently in the failed patients (34.2%
[28/82] vs. 19.7% [129/656]; p = 0.01). Severe calciﬁed lesions were
identiﬁed more often in the failed patients (27.0% [22/82] vs. 9.0% [59/
656]; p b 0.0001). Similarly, severely tortuous vessels were observed
more often in the failed patients (12.2% [10/82] vs. 5.2% [34/656];
p b 0.001). Regarding the procedural background, the procedure time
was signiﬁcantly longer in the failed group (236.0 ± 10.7 vs. 184.4 ±
3.4 min; p b 0.0001). The amount of skin radiation dose measured in
frontal view was signiﬁcantly greater in the failed patients (6.4 ± 0.6
vs. 4.7±0.2 Gy; p=0.002). Amongprocedural complications, coronary
perforation was observed more frequently in the failed group (31.7%
[26/82] vs. 9.0% [59/656]; p b 0.0001).3.2. Guidewire crossing strategy
The guidewire strategies adopted in all the procedures and in each
study group are shown in Table 3. The antegrade wiring strategy was
followed more often in the success group than in the failed group, and
the frequency of the CART and r-CART techniques was signiﬁcantly
higher in the success group (18.0% vs. 12.1%; p b 0.0001).Table 1
Patient characteristics in the success and failure groups.
Variables Success (656 pts) Failure (82 pts) p-Value
Age (years) 65.7 ± 0.4 67.6 ± 1.3 0.12
Male (%) 544 (82.9) 68 (82.9) 0.75
Diabetes mellitus 78 (11.9) 11 (13.4) 0.89
Hypertension 387 (59.0) 51 (62.2) 0.76
Hyperlipidemia 254 (38.7) 38 (46.3) 0.13
Familial history 97 (14.8) 8 (9.8) 0.24
Smoking 158 (24.1) 17 (20.7) 0.74
CKD 38 (5.8) 11 (13.4) 0.007
Preprocedural creatinine 1.4 ± 0.1 2.0 ± 0.3 0.03
Previous CABG 66 (10.1) 8 (9.8) 0.73
Preprocedural LVEF(%) 50.4 ± 12.5 45.8 ± 12.8 0.04
Values are median (interquartile range), or number, (%). Pts = patients; CKD = chronic
kidney disease; CABG= coronary artery bypass grafting; LVEF = left ventricular ejection
fraction.3.3. Factors in successful and failed CTO-PCI procedures that affect
long-term mortality
The phenomena that were observed to be predictive of the long-
term clinical outcome in the success and failed groups are shown in
Table 4. Radiational dermatitis was observed more often in the failed
group than in the success group (4.9% [4/82] vs. 1.1% [7/656]; p =
0.007). Successful CTO-PCI signiﬁcantly decreased the need for subse-
quent CABG (success group 2.1% [14/656] vs. failed group 8.5% [7/82];
p = 0.001). We also observed a trend toward a lower frequency of pre-
sentation of congestive heart failure in the success group (3.4% [22/656]
vs. 7.3% [6/82]; p = 0.07) as well as a signiﬁcantly lower incidence of
stroke (1.1% [7/656] vs. 4.9% [4/82]; p = 0.007).
Kaplan–Meier curves for the clinical endpoints at 2500 days are
shown in Fig. 2. The cumulative mortality of the success group was sig-
niﬁcantly lower than that of the failed group (log-rank test: p=0.0059;
9.8% [65/656] vs. 23.2% [19/82]; p=0.0003), aswas the incidence of ev-
ident cardiac death (3.5% [23/656] vs. 15.9% [13/82]; p b 0.0001).3.4. Logistic regression analysis
A Cox proportional-hazards model was used to identify variables in-
dependently associatedwith all-causemortality. Prior CABGhistory and
the presence of chronic kidney disease (CKD) were identiﬁed as unfa-
vorable independent factors (prior CABG: OR 1.94, 95% CI: 1.10–3.44;
p = 0.02; CKD: OR 2.59, 95% CI: 1.67–4.03; p b 0.001), whereas theTable 3
Guidewire strategies adopted in the success and the failure groups.
Variables Success (656 pts) Failure (82 pts. ) p-Value
Guidewire strategy
Parallel wire technique 163 (24.8) 34 (41.5) b0.0001
Success 110 (67) N/A
IVUS guided 53 (8.1) 12 (14.6) b0.0001
Success 39 (70) N/A
CART or r-CART 118 (18.0) 10 (12.1) b0.0001
Success 109 (92.3) N/A
Values are number, (%); IVUS = intravascular ultrasound; CART = controlled antegrade
and retrograde subintimal tracking; r-CART = reversed CART.
Table 4
Long-term clinical results in the success and failure groups.
Variables Success (656 pts) Failure (82 pts) p-value
Follow-up days 1531.3 ± 33.5 1565.3 ± 97.5 0.72
TVR 94 (14.3) N/A N/A
Reocclusion 42 (6) N/A N/A
Follow-up creatinine (mg/dL) 1.4 ± 0.1 1.9 ± 0.3 0.17
Follow-up LVEF(%) 53.5 ± 12.7 49.1 ± 10.3 0.11
Radiation dermatitis 7 (1.1) 4 (4.9) 0.007
Subsequent CABG 14 (2.1) 7 (8.5) 0.001
Subsequent hemodialysis 16 (2.4) 2 (2.4) –
CHF 22 (3.4) 6 (7.3) 0.07
Stroke 7 (1.1) 4 (4.9) 0.007
All cause death 64 (9.8) 19 (23.2) 0.0003
Evident cardiac death 23 (3.5) 13 (15.9) b0.0001
Values are number, (%); TVR = target vessel revascularization; CABG = coronary artery
bypass grafting; HD= hemodialysis; CHF= congestive heart failure; LVEF= left ventric-
ular ejection fraction.
Fig. 3. Results of logistic regression analysis. A Cox proportional-hazards model was used
to identify variables independently associatedwith all-causemortality. Prior CABGhistory
and the presence of CKD were identiﬁed as unfavorable independent factors (prior CABG:
OR 1.94, 95%: 1.10–3.44, p = 0.02; CKD: OR 2.59, 95% CI: 1.67–4.03, p b 0.001), while
the success of CTO-PCI was identiﬁed as a favorable independent factor for all-cause
mortality (OR 0.59; 95% CI: 0.35–0.99; p = 0.04). CABG = coronary artery bypass
grafting; CI = conﬁdence interval; CKD = chronic kidney disease; OR = odds ratio.
Other abbreviations as in Fig. 1.
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all-cause mortality (OR 0.59; 95% CI: 0.35–0.99; p = 0.04; Fig. 3).
4. Discussion
The results of this study demonstrate that a successful CTO-PCI pro-
cedure contributes to a better long-term clinical outcome compared
with failed CTO-PCI. Successful CTO-PCI signiﬁcantly decreased not
only all-cause death, but also evident cardiac death. Moreover, success-
ful CTO-PCI signiﬁcantly decreased the need for subsequent CABG and
numerically decreased the presentation of congestive heart failure and
stroke. Considering the results of this study, it is possible that successful
CTO-PCI contributes not only to lower long-termmortality, but also to a
better quality of life. Regarding the lesion background, severe calciﬁed
and tortuous lesions were associated with failed procedures. Regarding
theprocedural factors, a failed CTO-PCI required amuch longer time and
a greater radiation dose than a successful procedure andwas associated
with coronary perforation. According to the Cox proportional-hazards
model for all-cause death, success of CTO-PCI, age, body mass index,
the presence of CKD, and a prior history of CABG were associated with
better long-term mortality.
The initial success rate of CTO-PCI in Japan is over 80% [11]. However,
the long-term mortality after CTO has not been fully elucidated. We
would like to stress the signiﬁcance of this study, which demonstrates
not only the high initial success rate of CTO-PCI, but also its betterFig. 2. Kaplan–Meier curves for the clinical endpoints at 2500 days comparing the success
and failed group. The cumulative mortality of the success group was signiﬁcantly lower
than that of the failed group (log-rank test: p = 0.0059).long-term cardiacmortality. Since Japan is widely recognized as a coun-
try that has strong spirit of inquiry into CTO-PCI, we believe this study
adds signiﬁcantly to our knowledge regarding the long-term mortality
after successful CTO-PCI.
It is easy to understand why successful CTO-PCI would decrease the
incidence and the severity of CHF, and a high proportion of patients
treated successfully showed an improvement in left ventricular func-
tion; however, the lower frequency of stroke was unexpected. We
might speculate that successful treatment with CTO-PCI would contrib-
ute to an improvement in patients' attitude to healthpromotion, leading
to lifestyle and other changes that could decrease the risk of stroke.
More information about when stroke events occurred might help to-
ward interpreting this result.
Follow-up ejection fraction obtained by echocardiography was bet-
ter in both groups. However, it is not clear whether the successful
CTO-PCI or the optimal medical treatment was responsible for this im-
provement in LVEF. Further investigation is required to determine the
relative contributions of successful CTO-PCI and optimal medical treat-
ment to an improvement in long-term mortality.
4.1. Characteristics of the CTO-PCI candidate
Comparedwith the success group, more CKDpatients were included
in the failed group. This result might reﬂect the fact that patients on
chronic hemodialysis tended to be in the failed group. Heavily calciﬁed
coronary lesions are often encountered in chronic hemodialysis patients
in daily practice, and it has been reported that heavy calciﬁcation can be
a major obstacle to the success of CTO-PCI [8,9]. In this study, heavily
calciﬁed lesions were foundmore often in the failed group, as discussed
below, whichmeans that this result is consistent with previous reports.
4.2. Lesion and procedural background of CTO-PCI
The CTO was located in the left circumﬂex artery more often in the
failed group than in the success group. It has not been clearly reported
whether a lesion location in the left circumﬂex is a negative factor for
procedural success; however, the high angulation from the left main
to the left circumﬂex makes it difﬁcult to cross the lesion. Apart from
this issue, once a CTO lesion forms in a severely tortuous vessel it is
very difﬁcult to anticipate the trajectory of the vessel. In such a tortuous
CTO lesion, preprocedural computed tomography coronary angiogra-
phy is essential.
Failed CTO-PCI procedures required more time and a higher frontal
skin radiation dose than did successful procedures. The total amount
of contrast usedwasnumerically greater in the failed patients; however,
the difference did not reach statistical signiﬁcance. These negative fac-
tors associated with CTO-PCI were also within a high range even in
the patients with successful CTO-PCI. It has been reported that a suc-
cessful retrograde approach can ameliorate these limitations compared
32 T. Teramoto et al. / IJC Heart & Vasculature 14 (2017) 28–32with failed procedures [11]. Therefore, a retrograde approach can be a
good option for patients with CKD as a means of preserving their re-
maining renal function.
Regarding complications, coronary perforation was observed more
frequently in the failed group than in the success group. In this study,
the difference between the groups in the incidence of devastating coro-
nary perforation, which leads to an unstable hemodynamic state, did
not reach statistical signiﬁcance; however, the longer procedural time
andwiring difﬁculties in failed procedures can often result in the occur-
rence of complications such as coronary perforation.
4.3. Effect of guidewire strategy
Despite the higher frequency of retrograde attempts in the failed
group compared with the success group, the procedural success was
not satisfactory. In the failed group, the retrograde approach was
attempted as a ﬁnal resort; this ﬁndingmay thus be due to the complex-
ity of the lesions. Heavily calciﬁed lesionswere encounteredmore often
in the failed group than in the success group. Heavy calciﬁcation often
hinders the advance of the catheter via a retrograde approach, leaving
no alternative but to use the smallest size of balloon to dilate a greatly
calciﬁed lesion. It is probably safe to say that the degree of calciﬁcation
is the most important factor for the success of retrograde CTO-PCI.
4.4. Results of logistic regression analysis
In the Cox proportional-hazards model analysis, procedural success,
prior CABG, and the presence of CKD were the predictors found to be
signiﬁcantly associated with long-term mortality. It has been reported
that successful CTO-PCI improved long-term cardiac mortality [7,10].
Consistent with previous reports, our study demonstrates that success-
ful CTO-PCI was effective in improving the cardiac mortality of CTO
patients. In our study, patients with double CTO were excluded, so we
were able to speciﬁcally evaluate the effect of a single CTO lesion on
long-term cardiac mortality. It has been reported that the cardiac mor-
tality is better in CTO patients who undergo complete revascularization
than in those who undergo partial revascularization [10]. Thus, if pa-
tients with double CTO had been included in this study, the evaluation
of long-term mortality for each subgroup (partial and complete revas-
cularization) would have been more complicated.
4.5. Study limitations
There are several limitations to our study. First, differences in the
performance of the procedures as well as the varied clinical settings in-
volved in the performance of PCI could differ between countries; there-
fore, the results may also be variable. Second, the success of CTO-PCI is
highly dependent on a physician's skill and experience. Although expe-
rience in performing CTO-PCI has accumulated in our hospital, the re-
sults concerning acute success may be different under conditions with
less experience. Since this is a retrospective observational study, there
are also inherent limitations. Finally, it is likely that a previous history
of CABG and CKD would reﬂect the patient's frailty and general status.
In particular, the degree of renal dysfunction needs to be stratiﬁed and
related to the long-term mortality.
5. Conclusions
The initial success rate of CTO-PCI in Japan has reached a satisfactory
level. In linewith this development, the long-termmortality among pa-
tients who undergo successful CTO-PCI is better than in those in whom
CTO-PCI is unsuccessful. Multivariate analysis demonstrated thatprocedural success, a prior history of CABG, and the presence of CKD
were associated with long-term mortality.
Authors' information
Tomohiko TeramotoMD, Ph.D is the personwho designed this study
and wrote the manuscript. Estuo Tsuchikane MD, Masanori Yamamoto
MD and Masashi Kimura MD gave me a lot of important comments
and suggestions for the design of this study. Hitoshi Matsuo MD, Seiji
Kano MD, Tetsurou Shimura MD, and Hirotomo Sato MD discussed the
design of this study, and gave me a lot of important comments, and
helped data collection. Yoshiaki Kawase MD, Yoriyasu Suzuki MD,
Maoto HabaraMD, Kenya NasuMD, Yoshihisa KinoshitaMD, Mitsuyasu
TerashimaMD, Tetsuo Matsubara MD, and Takahiko Suzuki MD helped
make a draft of this manuscript with a lot of important suggestions.
Tomohiko Teramoto MD, PhD took charge of the analysis and interpre-
tation of data and approved the ﬁnal manuscript for the submission.
Funding sources
None.
Disclosures
None.
Acknowledgments
We thank Kazuki Shimizu for the data collection.
References
[1] A.R. Galassi, S.D. Tomasello, N. Reifart, et al., In-hospital outcomes of percutaneous
coronary intervention in patients with chronic total occlusion: insights from the
ERCTO (European Registry of Chronic Total Occlusion) registry, EuroIntervention 7
(2011) 472–479.
[2] M. Kimura, O. Katoh, E. Tsuchikane, et al., The efﬁcacy of a bilateral approach for
treating lesions with chronic total occlusions the CART (controlled antegrade and
retrograde subintimal tracking) registry, JACC Cardiovasc. Interv. 2 (2009)
1135–1141.
[3] J.A. Grantham, P.G. Jones, L. Cannon, J.A. Spertus, Quantifying the early health status
beneﬁts of successful chronic total occlusion recanalization: results from the
FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial,
Circ. Cardiovasc. Qual. Outcomes 3 (2010) 284–290.
[4] Z. Olivari, P. Rubartelli, F. Piscione, et al., TOAST-GISE Investigators. Immediate re-
sults and one-year clinical outcome after percutaneous coronary interventions in
chronic total occlusions: data from a multicenter, prospective, observational study
(TOAST-GISE), J. Am. Coll. Cardiol. 41 (2003) 1672–1678.
[5] A. Hoye, R.T. van Domburg, K. Sonnenschein, P.W. Serruys, Percutaneous coronary
intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002,
Eur. Heart J. 26 (2005) 2630–2636.
[6] D. Joyal, J. Aﬁlalo, S. Rinfret, Effectiveness of recanalization of chronic total occlu-
sions: a systematic review and meta-analysis, Am. Heart J. 160 (2010) 179–187.
[7] R. Mehran, B.E. Claessen, C. Godino, et al., Multinational Chronic Total Occlusion Reg-
istry. Long-term outcome of percutaneous coronary intervention for chronic total
occlusions, JACC Cardiovasc. Interv. 4 (2011) 952–961.
[8] T. Teramoto, E. Tsuchikane, H. Matsuo, et al., Initial success rate of percutaneous cor-
onary intervention for chronic total occlusion in a native coronary artery is de-
creased in patients who underwent previous coronary artery bypass graft surgery,
JACC Cardiovasc. Interv. 7 (2014) 39–46.
[9] Y. Morino, M. Abe, T. Morimoto, et al., J-CTO Registry Investigators. Predicting suc-
cessful guidewire crossing through chronic total occlusion of native coronary lesions
within 30minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difﬁcul-
ty grading and time assessment tool, JACC Cardiovasc. Interv. 4 (2011) 213–221.
[10] S. George, J. Cockburn, T.C. Clayton, et al., Long-term follow-up of elective chronic
total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit
Database, J. Am. Coll. Cardiol. 64 (2014) 235–243.
[11] M. Yamane,M. Muto, T. Matsubara, et al., Contemporary retrograde approach for the
recanalisation of coronary chronic total occlusion: on behalf of the Japanese Retro-
grade Summit Group, EuroIntervention 9 (2013) 102–109.
